On March 13, 2023, the board of directors of Amylyx Pharmaceuticals, Inc. appointed Karen Firestone to fill the vacancy on the Board as a Class I director, effective as of March 16, 2023 (the Effective Date), for an initial term expiring at the annual meeting of stockholders in 2025. Ms. Firestone has been appointed as a member of the Audit Committee and Nominating and Corporate Governance Committee.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.685 USD | -1.46% |
|
-4.26% | -88.55% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-88.55% | 116M | |
+0.46% | 91.38B | |
-3.16% | 38.68B | |
-10.34% | 33.58B | |
+72.31% | 27.84B | |
-12.50% | 16.05B | |
-0.10% | 13.48B | |
-9.38% | 11.73B | |
+172.59% | 10.74B | |
-49.44% | 10.39B |
- Stock Market
- Equities
- AMLX Stock
- News Amylyx Pharmaceuticals, Inc.
- Amylyx Pharmaceuticals, Inc. Appoints Karen Firestone as Class I Director